Dr Reddy’s Laboratories Q4FY25 results: Dr Reddy’s Laboratories, the country’s leading India-based pharmaceutical company, released its March quarter performance on Friday, May 9, reporting a 22% year-on-year jump in consolidated net profit to ₹1,594 crore, beating Street estimates of ₹1,491 crore.
Revenue also exceeded estimates, coming in at ₹8,506 crore compared to ₹7,083 crore in the same period last year, marking a growth of 20%.
